TrialJournal of gastroenterology2021

A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.

Zhe Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.